Heron Therapeutics (HRTX) Receivables - Other (2020 - 2025)
Heron Therapeutics' (HRTX) quarterly Receivables - Other came in at $160000.0 in Q4 2025, down 39.16% YoY from $263000.0 in Q4 2024, and down 39.16% on a QoQ basis from $263000.0 in Q4 2024.
Heron Therapeutics (HRTX) Receivables - Other (2020 - 2025) Analysis & Trends
Heron Therapeutics (HRTX) has 6 years of Receivables - Other data on file, last reported at $160000.0 in Q4 2025.
- Quarterly Receivables - Other fell 39.16% year-over-year to $160000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $160000.0 (down 39.16% YoY) and the FY2025 annual result came in at $160000.0, down 39.16% from the prior year.
- Receivables - Other eased to $160000.0 in Q4 2025, from $263000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $263000.0 in Q4 2024 to a low of $21000.0 in Q4 2023.
- A 5-year average of $140200.0 and a median of $154000.0 in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2023 — Receivables - Other plunged 86.36% — and 2024, when it jumped 1152.38%.
- Tracing HRTX's Receivables - Other over 5 years: stood at $103000.0 in 2021, then jumped by 49.51% to $154000.0 in 2022, then sank by 86.36% to $21000.0 in 2023, then jumped by 1152.38% to $263000.0 in 2024, then tumbled by 39.16% to $160000.0 in 2025.
- The last three Receivables - Other figures came in at $160000.0 (Q4 2025), $263000.0 (Q4 2024), and $21000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Heron Therapeutics | 58.32 Mn | 15.65 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Dec 31, 2020 | 334,000.00 |
| Dec 31, 2020 | 334,000.00 |